Section one: Contracting authority
one.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
Telephone
+44 1443848585
Country
United Kingdom
NUTS code
UK - United Kingdom
Internet address(es)
Main address
http://nwssp.nhs.wales/ourservices/procurement-services/
Buyer's address
https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer.
Reference number
PHW-STA-555
two.1.2) Main CPV code
- 33696500 - Laboratory reagents
two.1.3) Type of contract
Supplies
two.1.4) Short description
The provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £298,880
two.2) Description
two.2.2) Additional CPV code(s)
- 33696500 - Laboratory reagents
two.2.3) Place of performance
NUTS codes
- UKL - Wales
Main site or place of performance
Public Health Wales, NHS Trust.
two.2.4) Description of the procurement
The provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to consequences of the global pandemic, Covid-19, they are awarding a contract for the provision of goods and services to support Faecal Immunochemical Testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
The existing Bowel Screen Wales contract with Alpha Laboratories for Provision of Faecal Immunochemical Testing Analysers and Consumables was due to end in November 2021, and it was intended to go to market for the supply of Symptomatic and Screening Fit as one tender.
However, due to the outbreak of Covid-19 in 2020 and the subsequent suspension of routine hospital services and Screening across Wales; The Screening Division was approached to provide testing for patients presenting in Primary/Secondary care with symptoms of bowel cancer. Prior to Covid-19 these patients would be referred to Endoscopy. To ensure that urgent suspected cancers were identified during the pandemic, the decision was made to utilise Screenings existing FIT testing capability and service model.
To establish this service at short notice, the Screening Laboratory have entered contract with Alpha, the primary supplier of FIT to the Bowel Screening Wales Programme.
Appointing Alpha Laboratories as the single supplier was the most considered and beneficial approach to deliver the service and support the wider NHS needs in Wales. Due to the existing MSC arrangements in place with Alpha Laboratories for FIT Screening, the choice of this supplier would ensure: - Continuity of supply. - Compatibility with existing equipment and testing methodologies. - Reduced need for training - Existing patient material can be used to ensure patients complete their test correctly.
The Public Health Wales Screening Division do not have the resources to undertake a competitive procurement process through an open OJEU procedure currently due to supporting various screening and Covid activity.
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Aligning the FIT symptomatic workload with the contract already in place for the FIT screening is the only practical option to provide continued patient care. Going forward, both elements will be combined in the procurement of the existing contract for renewal.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2021/S 000-008738
Section five. Award of contract
Contract No
PHW-STA-555
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
1 April 2021
five.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from other EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Alpha Laboratories Ltd
40 Parham Drive, Eastleigh
Hampshire
SO504NU
Telephone
+44 02380487239
Country
United Kingdom
NUTS code
- UKJ3 - Hampshire and Isle of Wight
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £298,880
Section six. Complementary information
six.3) Additional information
(WA Ref:131351)
six.4) Procedures for review
six.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
Telephone
+44 2079477501
Country
United Kingdom
six.4.3) Review procedure
Precise information on deadline(s) for review procedures
NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.